Sulaiman Al-faqih Hospital Acquisition: A Defining Riyadh Expansion Signal

The transaction mechanics point to classic scale-building in a competitive city. Enterprise reporting said the target hospital opened in October 2022 and was operating 238 beds and 109 outpatient clinics out of a 192-clinic complex at the time of the agreement. Fakeeh Care’s existing Riyadh presence was described as a 185-bed hospital, and combining it with Al Fagih’s 350 beds created a 535-bed, two-site cluster. In a separate statement on completion, Fakeeh Care said its total bed capacity across the Kingdom increased to 1,185 beds, while bed capacity in Riyadh rose to approximately 535 beds. This larger footprint is positioned as harder to replicate quickly via organic builds alone, particularly in what Enterprise described as an “increasingly crowded” private-hospital market in Riyadh.

What the Deal Signals About Provider Consolidation

The Sulaiman Al-Faqih hospital acquisition story is also a payer-mix story. Fakeeh Care said the acquisition diversifies its customer base by adding more out-of-pocket patients and members covered by lower-tier insurance plans, alongside its existing focus on VIP and premium-insured patients. Enterprise described Al Fagih as bringing cash-pay demand and Class B / Network 6 insured volumes, with “cost synergies and revenue cross-pollination” as the core pitch. Those synergy claims were repeated in broader terms by company commentary that the integration should improve service efficiency and maximize utilization of medical expertise and modern technologies, with a positive impact on quality of care and patient experience.

Financial disclosures around the seller base and asset performance help explain why consolidation can accelerate. The sellers included Dallah Healthcare with 31.21%, founder Dr. Mohammed Rashid Al Fagih with 18.2%, and minority holders accounting for about 50.6%. Enterprise also reported Dallah’s share of proceeds as SAR 497.98 mn. On operating momentum, Enterprise said Al Fagih moved from a net loss of SAR 73 mn in 2023 to a net income of SAR 15.7 mn in 2024, rising to over SAR 48 mn in 2025. Revenue, it reported, increased 24% to SAR 466 mn in 2025, more than double the SAR 213 mn recorded in 2023. Improving profitability can make assets more “bankable,” helping both buyers and sellers justify transactions.

Funding structure and regulatory conditions show how listed operators are engineering these roll-ups. The acquisition was financed through a mix of internal resources and bank financing facilities, with disclosures stating it will increase consolidated debt levels due to acquisition financing and the assumption of the acquired company’s net outstanding debt. After signing, Enterprise reported Fakeeh secured SAR 2.2 bn across two shariah-compliant credit facilities: SAR 1.25 bn from Saudi National Bank and SAR 950 mn from Saudi Awwal Bank. The deal also required a General Authority for Competition non-objection and other consents. In parallel, Enterprise described this as part of a steady drumbeat of consolidation among listed operators, citing Dallah’s acquisitions of Kingdom Hospital, Makkah Medical Center, Al Salam, and most recently Al Ahsa, and National Medical Care’s deals for Jeddah’s Chronic Care Specialized Medical Hospital and Makkah’s Jiwar Medical Center.